
Contract research and manufacturing firm AMRI has acquired two businesses from pharmaceutical services company Aptuit in a $60 million deal. …

Drug development services firm Aptuit has named Dr Jonathan Goldman as its chief executive, completing the company’s senior management leadership …

An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …
Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles and Verum.de.
Catalent Pharma Solutions has agreed to purchase the clinical trial supply business of Aptuit in a $410 million deal which …
US contract manufacturing and drug development company Aptuit says it may shut down two facilities in Lothian, Scotland, because demand …

GlaxoSmithKline has sold off its medicines research facility in Verona, Italy, to contract research and manufacturing service group Aptuit in …

